U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. God Quest, Inc. d/b/a Creation Today - 522709 - 03/05/2018
  1. Warning Letters

CLOSEOUT LETTER

God Quest, Inc. d/b/a Creation Today MARCS-CMS 522709 —

Recipient:
God Quest, Inc. d/b/a Creation Today

United States

Issuing Office:

United States

 

   

Black HHS-Blue FDA LogoOffice of Regulatory Affairs
Office of Human and Animal Food Operations
East Division IV
Compliance Branch
466 Avenida Fernández Juncos
San Juan, Puerto Rico 00901-3223
Tel: (787) 729-8500

 

Office of Regulatory Affairs
Office of Human and Animal Food Operations
East Division IV
Compliance Branch
466 Avenida Fernández Juncos
San Juan, Puerto Rico 00901-3223
Tel: (787) 729-8500 
 
 

March 5, 2018

18-HAFE4-WLCOL-03

VIA UNITED PARCEL SERVICE
NEXT DAY - SIGNATURE REQUIRED

Mr. Eric M. Hovind, President
God Quest, Inc. d/b/a Creation Today
29 Cummings Road
Pensacola, FL 32503

Re: Warning Letter, 17-OHAFOED4-WL-06/CMS No.522709 dated 06/29/2017

Dear Mr. Hovind:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to Warning Letter, 17-OHAFOED4-WL-06/CMS No.522709 dated 06/29/2017. It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Kind regards,
/S/

Edwin Ramos
Director of Compliance Branch
OHAFO East Division IV

Back to Top